← Leaderboards
Francis J Novembre
Emory University
$5,562,216
Attributed
$5,562,216
Total exposure
21
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $835.1K · FY2005–11$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$5,562,216 · 21
By mechanism
R01$3,109,365 · 2
P51$1,852,851 · 18
R21$600,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Francois J Villinger$61,853,654
- Cynthia Ann Derdeyn$23,649,011
- Carlos Del Rio$49,445,541
- Aftab A. Ansari$22,344,206
- Shawn Patrick O'Neil$12,399,549
Others in their field
Top investigators on “Macaca”
- Barton F Haynes · Duke University$291,402,363
- Peter Gordon Gillespie · Oregon Health And Science University$96,229,141
- Richard A Gibbs · Baylor College Of Medicine$82,807,896
- Dennis R. Burton · Scripps Research Institute$75,153,374
- Larry S. Schlesinger · Texas Biomedical Research Institute$72,536,876
- Dan H. Barouch · Fred Hutchinson Cancer Center$68,546,715
Research focus
MacacaVirusResourcesSimian Immunodeficiency VirusUnited States National Institutes Of HealthSourceGrantFundingMacrophageResearch PersonnelPrimatesComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionHiv InfectionsAnimal TissueGenotypeAidsLymphatic SystemInflammationCommunicable DiseasesAnti-Retroviral AgentsAffectImmunologyPhenotype
Grant awards (29)
TOPICAL MICROBICIDE DRUG COMBINATIONS FOR THE PREVENTION OF SHIV$59,500
P51 · FY2011 · RR · contact PI
TOPICAL MICROBICIDE DRUG COMBINATIONS FOR THE PREVENTION OF SHIV$43,862
P51 · FY2010 · RR · contact PI
GENETICS OFNEUROPATHOGENIC SIV INFECTION$79,366
P51 · FY2009 · RR · contact PI
TOPICAL MICROBICIDE DRUG COMBINATIONS FOR THE PREVENTION OF SHIV$56,690
P51 · FY2009 · RR · contact PI
GENETICS OFNEUROPATHOGENIC SIV INFECTION$95,198
P51 · FY2008 · RR · contact PI
TOPICAL MICROBICIDE DRUG COMBINATIONS FOR THE PREVENTION OF SHIV$67,958
P51 · FY2008 · RR · contact PI
Genetics of Neuropathogenic SIV Infection$469,265
R01 · FY2007 · MH · contact PI
GENETICS OFNEUROPATHOGENIC SIV INFECTION$91,635
P51 · FY2007 · RR · contact PI
Genetics of Neuropathogenic SIV Infection$534,974
R01 · FY2006 · MH · contact PI
GENETICS OFNEUROPATHOGENIC SIV INFECTION$59,665
P51 · FY2006 · RR · contact PI
HIV ACTIVATION IN ALCOHOL-AIDED G VAGINALIS VIRULENCE$59,665
P51 · FY2006 · RR · contact PI
Genetics of Neuropathogenic SIV Infection$677,827
R01 · FY2005 · MH
HIV ACTIVATION IN ALCOHOL-AIDED G VAGINALIS VIRULENCE$52,438
P51 · FY2005 · RR
GENETICS OFNEUROPATHOGENIC SIV INFECTION$52,438
P51 · FY2005 · RR
EVALUATION OF A CANDIDATE MICROBICIDE ON HIV-1$52,438
P51 · FY2005 · RR
Genetics of Neuropathogenic SIV Infection$658,179
R01 · FY2004 · MH
COMBINATION DNA &ATTENUATE VIRUS VACCINE FOR SIV$95,071
P51 · FY2004 · RR
EVALUATION OF A CANDIDATE MICROBICIDE ON HIV-1$51,707
P51 · FY2004 · RR
GENETICS OFNEUROPATHOGENIC SIV INFECTION$51,707
P51 · FY2004 · RR
Genetics of Neuropathogenic SIV Infection$511,887
R01 · FY2003 · MH
COMBINATION DNA &ATTENUATE VIRUS VACCINE FOR SIV$87,166
P51 · FY2003 · RR
Combination DNA and Attenuated Virus Vaccine for SIV$280,000
R21 · FY2002 · AI
IMMUNOPATHOLOGY OF ACUTE SIV INFECTION$209,143
P51 · FY2002 · RR
PATHOGENESIS OF HIV 1 INFECTION IN CHIMPANZEES$209,143
P51 · FY2002 · RR
DETERMINANTS OF PATHOGENESIS IN SIVSMMPBJ INFECTION$209,143
P51 · FY2002 · RR
Combination DNA and Attenuated Virus Vaccine for SIV$320,000
R21 · FY2001 · AI
PATHOGENESIS OF HIV1 INFECTION$257,233
R01 · FY2000 · AI
PATHOGENESIS OF HIV 1 IN CHIMPANZEES$84,459
P51 · FY2000 · RR
DETERMINANTS OF PATHOGENESIS IN SIVSMMPBJ INFECTION$84,459
P51 · FY2000 · RR